[Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo]
- PMID: 9156505
- DOI: 10.1055/s-2007-997381
[Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo]
Abstract
Background: In the management of non-purulent acute sinusitis, alpha adrenergic substances are administered topically and secretolytics systemically. Antibiotic therapy should be restricted to purulent forms. This study was designed to demonstrate the importance of the maintenance of permanent ventilation and drainage of the sinuses as a therapeutic concept.
Patients/methods: In a multicentric trial the efficacy and safety of myrtol standardized and another essential oil were investigated in 331 patients with acute sinusitis in comparison to placebo. Three hundred thirty patients were evaluated in an intent-to-treat-analysis and 291 patients remained for statistical analysis. The study was conducted in 16 centers in a double-blind, double-dummy, randomized design versus placebo. During an observation-period of 14 days the patients were treated for 6 +/- 2 days with the respective study medication.
Results: With respect to efficacy, both myrtol standardized and the other essential oil proved to be significantly superior to placebo. As to the tolerance, a slight advantage of myrtol standardized was demonstrated in comparison to the other verum substance.
Conclusion: These results which do support the value of essential oils like myrtol as an effective treatment in acute, uncomplicated sinusitis instead of antibiotics as first choice, are confirmed by the existing literature.
Similar articles
-
Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.Arzneimittelforschung. 2000 Aug;50(8):700-11. doi: 10.1055/s-0031-1300276. Arzneimittelforschung. 2000. PMID: 10994153 Clinical Trial.
-
Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.Arzneimittelforschung. 1999 Apr;49(4):351-8. doi: 10.1055/s-0031-1300426. Arzneimittelforschung. 1999. PMID: 10337455 Clinical Trial.
-
[Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study].Arzneimittelforschung. 1998 Oct;48(10):990-4. Arzneimittelforschung. 1998. PMID: 9825116 Clinical Trial. German.
-
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.Treat Respir Med. 2004;3(4):247-68. doi: 10.2165/00151829-200403040-00005. Treat Respir Med. 2004. PMID: 15350163 Review.
-
Is Myrtol® Standardized a New Alternative toward Antibiotics?Pharmacogn Rev. 2016 Jul-Dec;10(20):143-146. doi: 10.4103/0973-7847.194045. Pharmacogn Rev. 2016. PMID: 28082798 Free PMC article. Review.
Cited by
-
Contribution of Symptomatic, Herbal Treatment Options to Antibiotic Stewardship and Microbiotic Health.Antibiotics (Basel). 2022 Sep 29;11(10):1331. doi: 10.3390/antibiotics11101331. Antibiotics (Basel). 2022. PMID: 36289988 Free PMC article. Review.
-
Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study).BMJ Open. 2018 Jan 31;8(1):e018788. doi: 10.1136/bmjopen-2017-018788. BMJ Open. 2018. PMID: 29391364 Free PMC article.
-
Evidence and evidence gaps in therapies of nasal obstruction and rhinosinusitis.GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016 Dec 15;15:Doc06. doi: 10.3205/cto000133. eCollection 2016. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016. PMID: 28025606 Free PMC article. Review.
-
Complementary and integrative treatments: rhinosinusitis.Otolaryngol Clin North Am. 2013 Jun;46(3):345-66. doi: 10.1016/j.otc.2013.02.002. Epub 2013 Apr 28. Otolaryngol Clin North Am. 2013. PMID: 23764814 Free PMC article. Review.
-
Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology.Eur Arch Otorhinolaryngol. 2012 Feb;269(2):389-97. doi: 10.1007/s00405-011-1755-z. Epub 2011 Sep 16. Eur Arch Otorhinolaryngol. 2012. PMID: 21922427 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials